Jci_page_head_homepage_01 Jci_page_head_homepage_02
Shmuel Muallem, Orson W. Moe
Published in Volume 117, Issue 8
J Clin Invest. 2007; 117(8):2086–2089 doi:10.1172/JCI33004
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2
Model of the autocrine/paracrine action of EGF in the DCT cell and potential mechanisms by which EGF can regulate TRPM6 activity.

Mg2+ influx across the luminal membrane is mediated by TRPM6 and may require the ubiquitous TRPM7. In this issue of the JCI, Groenestege et al. (11) report that EGF is a magnesiotropic hormone that regulates renal Mg2+ reabsorption by stimulating the EGFR, which then increases the activity of TRPM6. Aberrant targeting of pro-EGF to the basolateral membrane by the P1070L mutation results in reduced EGF production at the basolateral membrane, reduced activation of EGFR, reduced TRPM6 activity, and, consequently, Mg2+ wasting. Future studies should reveal which of the pathways activated by EGF mediates activation of TRPM6 and the mechanism by which TRPM6 activity is increased. As indicated by the long arrows, activation of EGFR by EGF and its tyrosine phosphorylation may directly activate TRPM6 and/or TRPM7 channel activity or may regulate insertion or retrieval or TRPM6 present in intracellular vesicular compartments. Because of the proximity of the DCT and proximal tubule, EGF generated by the DCT may activate EGFRs at the proximal tubule and therefore affect Mg2+ handling by this nephron segment, which reabsorbs 25% of filtered Mg2+. DAG, diacylglycerol; IP3, inositol-1,4,5 trisphosphate; PIP2, phosphatidylinositol 4,5-bisphosphate; PLCγ, phospholipase Cγ; P, phosphate.